CMR reveals myocardial damage from cardiotoxic oncologic therapies in breast cancer patients.
Johannes KerstenVisnja FinkMaria KerstenLisa MaySamuel NunnMarijana TadicJens HuoberInga BekesMichael RadermacherVinzenz HombachWolfgang RottbauerDominik BuckertPublished in: The international journal of cardiovascular imaging (2023)
Breast cancer patients receiving cardiotoxic chemotherapy show persistent deterioration in left ventricular strain values. This is accompanied by inflammatory changes in non-invasive tissue characterisation. Larger studies with longer follow-up periods are needed to identify patients at risk and establish preventive and therapeutic approaches.
Keyphrases
- left ventricular
- end stage renal disease
- oxidative stress
- chronic kidney disease
- newly diagnosed
- ejection fraction
- prognostic factors
- prostate cancer
- acute myocardial infarction
- hypertrophic cardiomyopathy
- squamous cell carcinoma
- rectal cancer
- mitral valve
- radical prostatectomy
- patient reported outcomes
- left atrial
- case control